Patient Support Services Contact Us
Image: Coherus Investors

Snapshot

Revenue & Earnings

Revenue (FY) $326.55
EBIT (Mil) (FY) $-263.86
EBIT (Mil) (MRQ) $-80.92
EBIT (Mil) (TTM) $-177.42
EBITDA (Mil) (FY) $-260.36
EBITDA (Mil) (MRQ) $-80.12
EBITDA (Mil) (TTM) $-173.95
Net Income Excluding Extraordinary Items (Mil) (FY) $-287.10
Net Income Including Extraordinary Items (Mil) (FY) $-287.10
Diluted EPS Excluding Extraordinary Items (FY) $-3.81
Diluted EPS Including Extraordinary Items (FY) $-3.81

Dividends

Yield (%) --
Dividend Record Date
Dividend Rate --

Ratios

Price to Revenue (TTM) $2.12
Price to Revenue (MRQ) $2.67
Price to Revenue (FY) $1.97
Price To Cash Flow (TTM) --
Price to Cash Flow (MRQ) --
Price to Cash Flow (FY) --
Price to Book (MRQ) $51.16
Price to Book (FY) $6.54
Total Debt to Equity (MRQ) (%) 3,346.78%
Total Debt to Equity (FY) (%) 419.05%
Current Ratio (MRQ) $3.33
Current Ratio (FY) $3.64

Growth

5-Year Annual Dividend Growth Rate (%) --%
5-Year Annual Revenue Growth Rate (%) 11.43%

FY = Fiscal Year. MRQ = Most Recent Quarter. mil = Millions. TTM = Trailing Twelve Months.

Copyright Refinitiv